血小板内皮细胞黏附分子-1与肿瘤

国际肿瘤学杂志››2014,Vol. 41››Issue (1): 4-7.doi:10.3760/cma.j.issn.1673422X.2014.01.002

血小板内皮细胞黏附分子-1与肿瘤

刘芳, 贾晓艳, 王若雨

116001大连大学附属中山医院肿瘤内科（刘芳、王若雨）；大连大学附属新华医院病理科（贾晓艳）

出版日期:2014-01-08发布日期:2014-01-22
通讯作者:王若雨，E-mail：wry1963@sohu.com E-mail:wry1963@sohu.com
基金资助:

国家自然科学基金（30970869）

Plateletendothelial cell adhesion molecule1 and tumor

LIU Fang, JIA Xiao-Yan, WANG Ruo-Yu

Department of Oncology, Affiliated Zhongshan Hospital of Dalian University, Dalian 116001, China

Online:2014-01-08Published:2014-01-22

摘要/Abstract

摘要：血小板内皮细胞黏附分子1（PECAM1）是免疫球蛋白超家族中的一种黏附分子，高表达于内皮细胞。近年来研究发现，PECAM1与肿瘤的发生、血管生成、细胞凋亡以及耐药均相关，可能对肿瘤的诊断与治疗产生重要影响。

刘芳, 贾晓艳, 王若雨. 血小板内皮细胞黏附分子-1与肿瘤[J]. 国际肿瘤学杂志, 2014, 41(1): 4-7.

LIU Fang, JIA Xiao-Yan, WANG Ruo-Yu. Plateletendothelial cell adhesion molecule1 and tumor[J]. Journal of International Oncology, 2014, 41(1): 4-7.

［1］ Privratsky JR, Paddock CM, Florey O, et al. Relative contribution of PECAM1 adhesion and signaling to the maintenance of vascular integrity［J］. J Cell Sci, 2011, 124(Pt 9):14771485. ［2］ Van Ierssel SH, Van Craenenbroeck EM, Hoymans VY, et al. Endothelium dependent vasomotion and in vitro markers of endothelial repair in patients with severe sepsis: an observational study［J］. PLoS One, 2013, 8(8):e69499. ［3］ Tourdot BE, Brenner MK, Keough KC, et al. Immunoreceptor tyrosinebased inhibitory motif (ITIM)mediated inhibitory signaling is regulated by sequential phosphorylation mediated by distinct nonreceptor tyrosine kinases: a case study involving PECAM1［J］. Biochemistry, 2013, 52(15):25972608. ［4］ Bergom C, Paddock C, Gao C, et al. An alternatively spliced isoform of PECAM1 is expressed at high levels in human and murine tissues, and suggests a novel role for the Cterminus of PECAM1 in cytoprotective signaling［J］. J Cell Sci, 2008, 121(Pt 8): 12351242. ［5］ Van den Broeck A, Vankelecom H, Van Delm W, et al. Human pancreatic cancer contains a side population expressing cancer stem cellassociated and prognostic genes［J］. PLoS One, 2013, 8(9):e73968. ［6］ Filová E, Brynda E, Riedel T, et al. Improved adhesion and differentiation of endothelial cells on surfaceattached fibrin structures containing extracellular matrix proteins［J］. J Biomed Mater Res A, 2013, In press. ［7］金春亭, 张凡, 常永霞, 等. 四种细胞黏附分子在老年宫颈癌浸润中的作用［J］. 中国老年医学杂志, 2007, 27(18):17961798. ［8］徐国萍, 张林, 苗杰, 等. 微血管密度与CD105、CD31在胃癌中的表达及意义［J］.胃肠病学和肝病学杂志， 2009, 18(6):524526. ［9］张丽静, 王圆圆, 李芳, 等. 结直肠癌发生过程中CD31与VEGF的表达［J］.中国现代医学杂， 2011, 21(1):14. ［10］ DeLisser H, Liu Y, Desprez PY, et al. Vascular endothelial platelet endothelial cell adhesion molecule 1 (PECAM1) regulates advanced metastatic progression［J］. Proc Natl Acad Sci USA, 2010, 107(43):1861618621. ［11］庄黛娜, 阎海强, 杨最素, 等. Cav1 mRNA、S100A4 mRNA和CD31的表达与前列腺癌转移及生存率关系的研究［J］. 中华泌尿外科杂志, 2012, 33(10):786790. ［12］ Pakalniskis MG, Wells WA, Schwab MC, et al. Tumor angiogenesis change estimated by using diffuse optical spectroscopic tomography: demonstrated correlation in women undergoing neoadjuvant chemotherapy for invasive breast cancer?［J］. Radiology, 2011, 259(2):365374. ［13］ Park S, DiMaio TA, Scheef EA, et al. PECAM1 regulates proangiogenic properties of endothelial cells through modulation of cellcell and cellmatrix interactions［J］. Am J Physiol Cell Phsiol, 2010, 299(6):C1468-1484. ［14］ Wu N, Kurosu T, Oshikawa G, et al. PECAM1 is involved in BCR/ABL signaling and may downregulate imatinibinduced apoptosis of Philadelphia chromosomepositive leukemia cells［J］. Int J Oncol, 2013, 42(2): 419-428. ［15］ Kushner EJ, Weil BR, MacEneaney OJ, et al. Human aging and CD31+ Tcell number, migration, apoptotic susceptibility, and telomere length［J］. J Appl Physiol, 2010, 109(6): 1756-1761. ［16］ Poggi A, Prevosto C, Catellani S, et al. Engagement of CD31 delivers an activating signal that contributes to the survival of chronic lymphocytic leukaemia cells［J］. Br J Haematol, 2010, 151(3):252-264. ［17］ Marfels C, Hoehn M, Wagner E, et al. Characterization of in vivo chemoresistant human hepatocellular carcinoma cells with transendothelial differentiation capacities［J］. BMC Cancer, 2013, 13: 176. ［18］ Ji XN, Yang F, Sui XM, et al. Effect of fractionated irradiation on the expression of multidrug resistance genes in the CNE1 human nasopharyngeal carcinoma cell line［J］. Mol Med Rep, 2013, 7(1): 187-194.

[1]	刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲.血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325.
[2]	杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊.局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337.
[3]	袁健, 黄燕华.Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343.
[4]	陈红健, 张素青.血清miR-24-3p、H2AFX与肝癌患者临床病理特征及术后复发的关系研究[J]. 国际肿瘤学杂志, 2024, 51(6): 344-349.
[5]	郭泽浩, 张俊旺.PFDN及其亚基在肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2024, 51(6): 350-353.
[6]	张百红, 岳红云.新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358.
[7]	许凤琳, 吴刚.EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363.
[8]	王盈, 刘楠, 郭兵.抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[9]	张蕊, 褚衍六.基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375.
[10]	高凡, 王萍, 杜超, 褚衍六.肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381.
[11]	王丽, 刘志华, 杨伟洪, 蒋凤莲, 李全泳, 宋浩杰, 鞠文东.ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J]. 国际肿瘤学杂志, 2024, 51(6): 382-384.
[12]	刘静, 刘芹, 黄梅.基于SMOTE算法的食管癌放化疗患者肺部感染的预后模型构建[J]. 国际肿瘤学杂志, 2024, 51(5): 267-273.
[13]	杨琳, 路宁, 温华, 张明鑫, 朱琳.炎症负荷指数与胃癌临床关系研究[J]. 国际肿瘤学杂志, 2024, 51(5): 274-279.
[14]	王俊毅, 洪楷彬, 纪荣佳, 陈大朝.癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285.
[15]	张宁宁, 杨哲, 檀丽梅, 李振宁, 王迪, 魏永志.宫颈细胞DNA倍体分析联合B7-H4和PKCδ对宫颈癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(5): 286-291.